NEW YORK, Feb. 18, 2024 /PRNewswire/ — The sex reassignment surgery market in US is to grow by USD 125.78 million from 2022 to 2027 progressing at a CAGR of 10.84% during the forecast period. Key companies include- Boston Childrens Hospital, Boston Medical Center, Cedars Sinai Health System, CNY Cosmetic and Reconstructive Surgery, Cornell University, Denver Health, Harvard University, Icahn School of Medicine at Mount Sinai, Mass General Brigham Inc., Moein Surgical Arts, NorthWestern University, Oregon Health and Science University, Plastic Surgery Group of Rochester, Regents of the University of Michigan, Stanford University, The Cleveland Clinic Foundation, The Johns Hopkins Health System Corp., The Regents of the University of California, The University of Utah, Transgender Surgery Institute. For more insights Buy Report now!
|
Report Coverage |
Details |
|
Page number |
109 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 10.84% |
|
Market growth 2023-2027 |
USD 125.78 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
8.63 |
Company Offering
- Moein Surgical Arts – The company offers sex reassignment surgery, such as male-to-female gender reassignment surgery.
- Cedars Sinai Health System – The company offers sex reassignment surgery, such as bilateral orchiectomy.
- Denver Health – The company offers sex reassignment surgery, such as orchiectomy. Gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform
The market is driven by an increase in the number of people opting for sex change surgeries in the US. The number of transgender surgeries performed each year in the US ranges from 100 to 500. According to the 2020 plastic surgery statistics provided by ASPS, transgender women have undergone 6,368 gender confirmation surgeries. in the US, compared with 5,616 in 2019. In addition, 1,231 genital surgery transgender surgeries, 4,035 thoracoscopic or thoracoscopic surgeries, and 1,102 facial surgeries were performed in 2020. Hence, these factors are expected to drive market growth during the forecast period. – Here is an Exclusive report talking about Market scenarios with a historical period (2017-2021) and forecast period (2023-2027). Download Sample Report in minutes!
The analysis includes the type (male to female and female to male), and end-user (hospitals and clinics)
- The growth by the male-to-female segment will be significant during the forecast period. Male-to-female SRS surgery is the transformation of male genitalia into a shape that has the appearance and to some extent function of female genitalia. Patients are treated with female hormones before surgery to look more feminine. Orchiectomy, which includes the removal of the testicle, is one of the main processes involved in SRS surgery between men and women. Hence, such factors are expected to drive the growth of this segment during the forecast period. This report presents a detailed picture by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters- View Sample Report
The U.S. sex reassignment surgery market is witnessing significant growth, driven by increasing awareness of transgender issues and the rising demand for gender affirmation surgeries among individuals with gender dysphoria. Transgender males and females, including the young transgender population, seek procedures such as SRS to align their physical characteristics with their self-identified gender. With the mean age of patients undergoing SRS being around 7 years, there’s a notable emphasis on catering to the needs of the transfeminine population. Leading institutions like the Mount Sinai Center for Transgender Medicine and Surgery play a pivotal role in providing comprehensive care and specialized procedures tailored to transgender individuals in the U.S.
The industry is influenced by various factors, including the availability and accessibility of gender reassignment surgical centers. Government reimbursement policies, particularly under the Affordable Care Act, also play a significant role, impacting coverage for procedures related to transgender individuals. Lesbian, Gay, Bisexual, & Transgender (LGBT) individuals often rely on insurance providers like Unicare and Aetna for coverage of surgeries such as hysterectomy, salpingo-oophorectomy, orchiectomy, and ovariectomy. These procedures may be covered under specific plans or through the Medicaid program, which provides essential healthcare services to low-income individuals. As societal awareness grows, ensuring equitable access to SRS surgeries remains a key focus for policymakers and healthcare providers in the United States.
Related Reports:
The hereditary angioedema (HAE) therapeutics market is estimated to grow by USD 1,647.38 million at a CAGR of 8.95% between 2022 and 2027.
The photodynamic therapy market is estimated to grow by USD 2,053.68 million at a CAGR of 8.22% between 2022 and 2027.
Table of Contents
1 Executive Summary
2 Landscape
3 Sizing
4 Historic Size
5 Five Forces Analysis
6 Segmentation by End User
7 Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Company Landscape
12 Company Analysis
13 Appendix
About US
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging trends and provide actionable insights to help businesses identify opportunities and develop effective strategies to optimize their positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable insights to identify opportunities in existing and potential markets and assess their competitive positions within changing scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
